Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approvals for their generic versions of Decitabine and Fosaprepitant for injection. The company has immediately commenced shipping of Fosaprepitant, which coincides with the first day of patent expiration for the brand EMEND©, marketed by Merck. Novadoz expects to begin the shipping of Decitabine, their generic version of DACOGEN© from Otsuka, later this month.
